Guidance
Update information
November 2021: We withdrew recommendations 1.6.1 to 1.6.4 on valvular surgery and percutaneous intervention because they have been replaced by the NICE guideline on heart valve disease.
Minor changes since publication
March 2016: MHRA advice on spironolactone and renin-angiotensin system drugs added to recommendation 1.5.4.
ISBN: 978-1-4731-0780-9